VALBIOTIS: Financial Communication Calendar for 2018
23 Fevereiro 2018 - 10:30AM
Business Wire
Regulatory News:
VALBIOTIS (Paris:AVAL) (FR0013254851 - ALVAL / PEA/SME
eligible), a company that specializes in developing innovative
nutrition solutions designed to prevent cardiometabolic diseases
and provide nutritional support for patients, today presents its
financial communication calendar for 2018:
- April 3, 2018: Publication of
2017 financial statements (pre-market)
- April 5, 2018: Portzamparc
MidCap Conference 2018
- June 27-28, 2018: Spring
European Midcap Event 2018, Paris
- July 3, 2018: “Journée
Nutrition” - SFAF
- September 28, 2018: Publication
of the Half Year 2018 financial statements(after market)
- October 8-9, 2018: European
Large & Midcap Event Paris 2018
- December 4-5, 2018: Geneva
European Midcap Event 2018
- December: Biomed Event Paris –
Invest Securities
In order to strengthen its relationships with its shareholders,
VALBIOTIS has decided to start editing and circulating a “Letter to
the shareholders”, on a regular basis. The first issue was printed
and sent by mail in February 2018.
A corporate presentation has also been updated in February
2018.
Both digital documents are available on the company website, at
the following link: http://VALBIOTIS.com/en/documentation/
ABOUT VALBIOTIS
VALBIOTIS specializes in developing innovative nutrition
solutions designed to prevent cardiometabolic diseases and provide
nutritional support for patients. Its products are made for
manufacturers in the agri-food and pharmaceutical industries.
VALBIOTIS particularly focuses on solutions to prevent type 2
diabetes, NASH (nonalcoholic steatohepatitis), obesity and
cardiovascular diseases.
VALBIOTIS was founded in La Rochelle in early 2014 and has
formed numerous partnerships with top academic centers in France
and abroad, including the La Rochelle University, the CNRS and the
Clermont Auvergne University located in Clermont-Ferrand, where the
company opened a second office. These agreements enable it to
benefit from a considerable leverage effect since it was set up
thanks, in particular, to the experts and technical partners
mobilized for these projects. VALBIOTIS is a member of the “BPI
Excellence” network and received the “Innovative Company” status
accorded by BPI France. VALBIOTIS has also been awarded “Young
Innovative Company” status and has received major financial support
from the European Union for its research programs by obtaining
support from the European Regional Development Fund (ERDF).
Find out more about
VALBIOTIS:http://VALBIOTIS.com/
Name: VALBIOTISISIN code:
FR0013254851Mnemonic Code: ALVAL
View source
version on businesswire.com: http://www.businesswire.com/news/home/20180223005174/en/
FINANCIAL COMMUNICATIONACTIFINStéphane Ruiz, +33 1 56 88
11 14sruiz@actifin.frorPRESS RELATIONSALIZE PRCaroline
Carmagnol / Wendy Rigal+33 1 44 54 36
66VALBIOTIS@alizerp.comorCOMMUNICATIONS
DEPARTMENTVALBIOTISMarc Delaunay, +33 5 46 28 62
58marc.delaunay@VALBIOTIS.com
Grupo Aval Acciones y Va... (NYSE:AVAL)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Grupo Aval Acciones y Va... (NYSE:AVAL)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024
